MT694662
Miniopterus fuliginosus isolate N20159 D-loop, partial sequence; mitochondrial.
294
DNA
Miniopterus fuliginosus
N20159
yx41b05.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:264273 3', mRNA sequence.
457
mRNA
Homo sapiens
MC903897
JP 2018536623-A/20159: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
35
PRT
synthetic construct
OG656545
JP 2021500321-A/20159: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
PD708073
JP 2021530475-A/20155: De novo Design of Protein Switches.
60
PRT
synthetic construct
HZ524940
JP 2016501039-A/20159: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
LV565981
JP 2017029159-A/20159: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
MD266292
JP 2020517247-A/20159: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
MC162003
JP 2019500349-A/20159: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
FU794640
JP 2009528046-A/20157: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
HV876700
JP 2010507387-A/20111: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
HW855383
JP 2015051004-A/20111: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
LF679380
JP 2016521556-A/20159: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
PA524643
JP 2022502046-A/7425: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
LX117775
JP 2017506877-A/20157: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
LF827315
JP 2016528161-A/20148: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
LZ207236
JP 2017148060-A/20159: OLIGONUCLEOTIDE MODULATORS OF THE TOLL-LIKE RECEPTOR PATHWAY.
18
RNA
synthetic construct
HW567224
JP 2014509511-A/20159: OLIGONUCLEOTIDE MODULATORS OF THE TOLL-LIKE RECEPTOR PATHWAY.
18
RNA
synthetic construct
PA335807
JP 2021522188-A/20159: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
DM756853
JP 2014079248-A/20159: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
DL029173
JP 2005512499-A/20159: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
1482
DNA
synthetic construct
DD800429
JP 2008525033-A/20159: Group B Streptococcus.
876
PRT
Streptococcus agalactiae
DL610761
JP 2011092200-A/20159: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
OG749678
JP 2021120380-A/20159: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
MC548659
JP 2019525738-A/20159: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
10
PRT
synthetic construct
DJ523959
JP 2010517930-A/20159: Method of constructing and screening libraries of peptide structures.
22
PRT
synthetic construct
DM794617
JP 2014068652-A/20159: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
DJ149539
JP 2007228956-A/20157: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
DD546762
JP 2004508801-A/20159: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
DM721304
JP 2016500250-A/20159: ENGINEERED SECRETED PROTEINS AND METHODS.
686
PRT
Escherichia coli